Board Memorandum

Sovereign Mandate

SaudiVax is not a conventional biopharmaceutical company. It is a strategic instrument of the Kingdom of Saudi Arabia's National Biotechnology Strategy — engineered to eliminate sovereign dependency on imported vaccines and biologics, and to catalyze a $34.6B biotech GDP by 2040.

Mission Statement

Localize. Manufacture. Protect.

To localize the end-to-end development and manufacturing of high-quality vaccines and biologics, ensuring a reliable supply for Saudi Arabia and the MENA region while cultivating a world-class hub for biotech innovation and sovereign talent development.

100%

Vaccine Localization Target

Active Pipeline Candidates

Technology Platforms

Strategic Vision

The Regional Biotech Sovereign

To be the leading biopharmaceutical enterprise in the MENA region — safeguarding public health, driving a knowledge-based economy, and establishing Saudi Arabia as a self-sufficient and globally recognized force in biotechnology. Aligned directly with Vision 2030's economic diversification mandate and the National Biotechnology Strategy's target of $34.6B biotech GDP contribution.

Vision 2030 Aligned SFDA Regulated GMP Certified

Governance & Capital

Board of Directors

The strategic apex of SaudiVax — providing sovereign capital, institutional vision, and fiduciary oversight of the Kingdom's biopharmaceutical mandate.

Dr. Mazen Fakeeh

Chairman of the Board

Founder of Fakeeh Care Group — Saudi Arabia's largest integrated private healthcare network. Anchor investor and strategic architect of SaudiVax's sovereign biomanufacturing mandate.

Prof. Mazen M. Hassanain

Managing Director

MD, PhD — McGill University. Professor of Surgery, King Saud University. 12+ patents in biopharmaceutical manufacturing. 200+ peer-reviewed publications with h-index 42.

Independent Director

Panagiotis Chatziantoniou

International regulatory governance & cross-border strategic advisory

Independent Director

Prof. Anwar Hashem

Biopharmaceutical science governance & academic counsel

Operations & Science

Executive Leadership

The operational command driving SaudiVax from mandate to manufacturing — bridging sovereign vision with scientific execution.

Prof. Mazen M. Hassanain

Managing Director

Degree MD, PhD — Biomedical Engineering, McGill University

Faculty Professor of Surgery, King Saud University

Patents 12+ biopharmaceutical manufacturing patents

Research 200+ publications, h-index 42

Ashraf Dehlawi

Chief Operating Officer

Focus End-to-end pharmaceutical manufacturing operations

Expertise cGMP facility commissioning & supply chain optimization

Oversight Production, quality assurance, distribution & logistics

Essam Aljindy

Deputy Chief Technology Officer

Focus Biomanufacturing infrastructure & technology transfer

Expertise R&D pipeline integration & process automation

Oversight Laboratory systems, data architecture & plant technology

Institutional Scale

Operational Framework

A sovereign enterprise operating across four integrated divisions — each staffed with domain specialists and governed by dedicated committee oversight.

Committee

Scientific & Advisory

Directing preclinical & clinical strategy, pipeline prioritization, and scientific due diligence across all technology platforms.

Prof. Anwar Hashem — Chair

Committee

Risk & Audit

Enterprise risk management, financial oversight, internal controls, and regulatory compliance across sovereign operations.

P. Chatziantoniou — Chair

Division

Regulatory Affairs & QC

SFDA regulatory submissions, quality control protocols, batch release testing, and GMP compliance for all manufacturing lines.

Regulatory Affairs Division

Division

Manufacturing Ops

End-to-end biomanufacturing execution — upstream cell culture through downstream purification, fill-finish, and cold-chain distribution.

Manufacturing Operations Division

Institutional Principles

Core Values

Integrity

Upholding the highest ethical standards in research, manufacturing, and business practices — transparent and accountable to the Kingdom and its people.

Innovation

Relentlessly pursuing scientific and technological breakthroughs to solve pressing health challenges facing the region.

Collaboration

Building powerful partnerships with academia, industry, and government to accelerate progress toward sovereign biomanufacturing.

Excellence

Committing to world-class quality and execution in everything we do, from the laboratory to the manufacturing floor.

Join the Sovereign Mandate

We are building a team of the brightest minds in science, engineering, and business. If you are driven by purpose and want to shape the future of biotechnology in the Kingdom, we want to hear from you.

Explore Careers Contact Leadership